Zhuoran Yin

Zhuoran Yin

Auto-generated profile, based on publicly available information

Zhuoran Yin

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2015 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
IHInge R Holtman
Inge R Holtman
DRDivya D A Raj
Divya D A Raj
JMJeremy A Miller
Jeremy A Miller
WSWandert Schaafsma
Wandert Schaafsma
ZYZhuoran Yin
Zhuoran Yin
BEBart J L Eggen
Bart J L Eggen
Microglia are tissue macrophages of the central nervous system that monitor brain homeostasis and react upon neuronal damage and stress. Aging and neurodegeneration induce a hypersensitive, pro-inflammatory phenotype, referred to as primed microglia. To determine the gene expression signature of priming, the transcriptomes of microglia in aging, Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS) mouse models were compared using Weighted Gene Co-expression Network Analysis (WGCNA). A highly consistent consensus transcriptional profile of up-regulated genes was identified, which prominently differed from the acute inflammatory gene network induced by lipopolysaccharide (LPS). Where the acute inflammatory network was significantly enriched for NF-κB signaling, the primed microglia profile contained key features related to phagosome, lysosome, antigen presentation, and AD signaling. In addition, specific signatures for aging, AD, and ALS were identified. Microglia priming induces a highly conserved transcriptional signature with aging- and disease-specific aspects.

1 July 2017 in Neurobiology of Aging
Verified
Journal Article
Closed access
ZYZhuoran Yin
Zhuoran Yin
DRDivya Raj
Divya Raj
NSNasrin Saiepour
Nasrin Saiepour
DDDebby Van Dam
Debby Van Dam
NBNieske Brouwer
Nieske Brouwer
EBErik Boddeke
Erik Boddeke

30 June 2017 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
DRDivya Raj
Divya Raj
ZYZhuoran Yin
Zhuoran Yin
MBMarjolein Breur
Marjolein Breur
JDJanine Doorduin
Janine Doorduin
IHInge R. Holtman
Inge R. Holtman
EBErik Boddeke
Erik Boddeke
Chronic neuroinflammation, which is primarily mediated by microglia, plays an essential role in aging and neurodegeneration. It is still unclear whether this microglia-induced neuroinflammation occurs globally or is confined to distinct brain regions. In this study, we investigated microglia activity in various brain regions upon healthy aging and Alzheimer’s disease (AD)-related pathology in both human and mouse samples. In purified microglia isolated from the aging mouse brain, we found a profound gene expression pattern related to pro-inflammatory processes, phagocytosis, and lipid homeostasis. Particularly in white matter microglia of 24-month-old mice, abundant expression of phagocytic markers including Mac-2, Axl, CD16/32, Dectin1, Cd11c, and Cd36 was detected. In white matter of human brain the first signs of inflammatory activity were already detected during middle age. Quantification of microglial proteins, such as CD68 (commonly associated with phagocytosis) and HLA-DR (associated with antigen presentation), in postmortem human white matter brain tissue showed an age-dependent increase in immunoreactivity already in middle-aged people (53.2 ± 2.0 yr), which was also detectable by non-invasive positron emission tomography (PET) imaging using [11C]-(R)-PK11195, a ligand that binds to activated microglia. Increased microglia activity was also prominently present in the white matter of human early-onset postmortem AD (EOAD) brains. Interestingly, microglia activity in the white matter of late-onset AD (LOAD) CNS was similar to that of the aged clinically-silent AD cases. These data indicate that microglia-induced neuroinflammation is predominant in the white matter of aging mice and humans as well as in EOAD brains. This white matter inflammation may contribute to the progression of neurodegeneration, and have prognostic value for detecting the onset and progression of aging and neurodegeneration.

12 March 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
ZYZhuoran Yin
Zhuoran Yin
DRDivya D. Raj
Divya D. Raj
WSWandert Schaafsma
Wandert Schaafsma
RHRoel A. van der Heijden
Roel A. van der Heijden
SKSusanne M. Kooistra
Susanne M. Kooistra
BEBart J. L. Eggen
Bart J. L. Eggen
Rodent models of both aging and obesity are characterized by inflammation in specific brain regions, notably the corpus callosum, fornix, and hypothalamus. Microglia, the resident macrophages of the central nervous system, are important for brain development, neural support, and homeostasis. However, the effects of diet and lifestyle on microglia during aging are only partly understood. Here, we report alterations in microglia phenotype and functions in different brain regions of mice on a high-fat diet (HFD) or low-fat diet (LFD) during aging and in response to voluntary running wheel exercise. We compared the expression levels of genes involved in immune response, phagocytosis, and metabolism in the hypothalamus of 6-month-old HFD and LFD mice. We also compared the immune response of microglia from HFD or LFD mice to peripheral inflammation induced by intraperitoneal injection of lipopolysaccharide (LPS). Finally, we investigated the effect of diet, physical exercise, and caloric restriction (40% reduction compared to ad libitum intake) on microglia in 24-month-old HFD and LFD mice. Changes in diet caused morphological changes in microglia, but did not change the microglia response to LPS-induced systemic inflammation. Expression of phagocytic markers (i.e., Mac-2/Lgals3, Dectin-1/Clec7a, and CD16/CD32) in the white matter microglia of 24-month-old brain was markedly decreased in calorically restricted LFD mice. In conclusion, LFD resulted in reduced activation of microglia, which might be an underlying mechanism for the protective role of caloric restriction during aging-associated decline.

15 September 2017 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
ZYZhuoran Yin
Zhuoran Yin
FVFemke Valkenburg
Femke Valkenburg
BHBetty E. Hornix
Betty E. Hornix
IMIetje Mantingh-Otter
Ietje Mantingh-Otter
XZXingdong Zhou
Xingdong Zhou
EBErik Boddeke
Erik Boddeke
Tauopathies include a variety of neurodegenerative diseases associated with the pathological aggregation of hyperphosphorylated tau, resulting in progressive cognitive decline and motor impairment. The underlying mechanism for motor deficits related

15 January 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
WBWesley Brandao
Wesley Brandao
NJNimansha Jain
Nimansha Jain
ZYZhuoran Yin
Zhuoran Yin
KKKilian L. Kleemann
Kilian L. Kleemann
MCMadison Carpenter
Madison Carpenter
OBOleg Butovsky
Oleg Butovsky
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder. Antiamyloid antibody treatments modestly slow disease progression in mild dementia due to AD. Emerging evidence shows that homeostatic dysregulation of the brain immune system, especially that orchestrated by microglia, plays an important role in disease onset and progression. Thus, a major question is how to modulate the phenotype and function of microglia to treat AD. Xenon (Xe) gas is a noble gas used in human patients as an anesthetic and a neuroprotectant used for treating brain injuries. Xe penetrates the blood-brain barrier, which could make it an effective therapeutic. To assess the effect of Xe on microglia and AD pathology, we designed a custom Xe inhalation chamber and treated several mouse models of AD with Xe gas. Xe treatment induced mouse microglia to adopt an intermediate activation state that we have termed pre–neurodegenerative microglia (pre-MGnD). This microglial phenotypic transition was observed in mouse models of acute neurodegeneration and amyloidosis (APP/PS1 and 5xFAD mice) and tauopathy (P301S mice). This microglial state enhanced amyloid plaque compaction and reduced dystrophic neurites in the APP/PS1 and 5xFAD mouse models. Moreover, Xe inhalation reduced brain atrophy and neuroinflammation and improved nest-building behavior in P301S mice. Mechanistically, Xe inhalation induced homeostatic brain microglia toward a pre-MGnD state through IFN-γ signaling that maintained the microglial phagocytic response in APP/PS1 and 5xFAD mice while suppressing the microglial proinflammatory phenotype in P301S mice. These results support the translation of Xe inhalation as an approach for treating AD.